Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

The Dana Foundation

Information provided by (Responsible Party):

University of Colorado, Denver

ClinicalTrials.gov Identifier:

NCT01409915

First received: August 2, 2011

Last updated: May 22, 2017

Last verified: May 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2017
Estimated Primary Completion Date:	November 2017 (Final data collection date for primary outcome measure)